Skip to main content
logo
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.0937
-0.0089 (-8.67%)
At close: Nov 6, 2026, 4:00 PM EST
0.0955
+0.0018 (1.92%)
After-hours: Nov 6, 2026, 7:39 PM EST

Vivos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2182515952
Market Cap Growth
-89.66%-27.79%69.64%61.00%-82.13%-50.41%
Enterprise Value
13282116525
Last Close Price
0.092.034.2912.4410.0556.25

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.091.051.681.080.583.07
PB Ratio
--11.773.1836.241.932.03
P/TBV Ratio
--5.37-5.592.32

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.601.591.371.160.341.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-3.14-8.710.194.850.500.05
Net Debt / Equity Ratio
-2.69-7.40-0.600.86-0.23-0.89
Net Debt / EBITDA Ratio
-0.52-0.620.45-0.020.051.22
Net Debt / FCF Ratio
-0.56-0.650.36-0.030.051.26
Asset Turnover
0.830.861.161.130.680.57
Quick Ratio
0.160.201.340.250.583.43
Current Ratio
0.210.241.500.340.803.64
Return on Equity (ROE)
-8585.26%-663.02%-266.25%-521.22%-157.19%-92.31%
Return on Assets (ROA)
-56.19%-61.50%-53.68%-88.42%-66.00%-41.24%
Return on Capital Employed (ROCE)
-600.60%-281.10%-108.40%-502.60%-362.40%-74.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1949.48%-116.03%-44.07%-91.20%-257.76%-39.18%
FCF Yield
-1008.62%-96.48%-52.48%-85.93%-221.72%-35.02%
Buyback Yield / Dilution
-72.97%-104.66%-311.68%-32.46%-8.39%-65.00%
SEC Filings: 10-K · 10-Q